Webcast:

The Right Antibiotic: Principles of Appropriate Antimicrobial Therapy.

(English)

(Vietnamese)

Alt tag

Webcast:

The Right Antibiotic: Principles of Appropriate Antimicrobial Therapy.

(English)

(Vietnamese)

About this webcast

In this presentation Professor Ronald F. Grossman will use the clinical setting of pneumonia to address appropriate use of antimicrobials, diagnosing infection and prescribing therapy appropriate to the suspected or diagnosed infection.

 

  • Learn how using appropriate dosing and treatment duration can optimise antibiotic therapy in accordance with management guidelines.

  • Learn the key criteria for selecting empirical therapy.

 

(English)

(Vietnamese)

Speakers

Image alt

Ronald F. Grossman

Professor of Medicine

University of Toronto, Ontario, Canada

Ronald F. Grossman is Professor of Medicine at the University of Toronto, Ontario, and previous Chief of Medicine, Credit Valley Hospital, Mississauga, Ontario, Canada.

He has served as Chairman of the National Information Program on Antibiotics, a coalition of many medical and public health societies. This coalition was established to encourage the appropriate use of antibiotics among physicians and patients.

Professor Grossman’s major research and teaching interests are in respiratory tract infections. He has participated in the creation of Canadian and American guidelines for the management of community-acquired pneumonia, Canadian guidelines for the management of hospital-acquired pneumonia and Canadian and international guidelines for the management of acute exacerbations of chronic obstructive lung disease. 

He has published over 90 articles in a wide number of medical journals including the New England Journal of Medicine, the American Journal of Respiratory Critical Care Medicine, the American Journal of Medicine and Chest.

(English)

(Vietnamese)

If you have observed any unwanted or adverse effect, or have a quality complaint related to a Bayer product, we would be interested to hear about it as part of our ongoing pharmacovigilance processes. You may report these to us through our Bayer Side Effect Reporting website.